Vijay K Iyengar - Net Worth and Insider Trading

Vijay K Iyengar Net Worth

The estimated net worth of Vijay K Iyengar is at least $3 Million dollars as of 2023-05-31. Vijay K Iyengar is the EVP, GMAPPS of Incyte Corp and owns about 42,835 shares of Incyte Corp (INCY) stock worth over $3 Million. Details can be seen in Vijay K Iyengar's Latest Holdings Summary section.

Transaction Summary of Vijay K Iyengar

To

Vijay K Iyengar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vijay K Iyengar owns 1 companies in total, including Incyte Corp (INCY) .

Click here to see the complete history of Vijay K Iyengar’s form 4 insider trades.

Insider Ownership Summary of Vijay K Iyengar

Ticker Comapny Transaction Date Type of Owner
INCY Incyte Corp 2016-05-09 EVP GPS & BD & & Licensing

Vijay K Iyengar Latest Holdings Summary

Vijay K Iyengar currently owns a total of 1 stock. Vijay K Iyengar owns 42,835 shares of Incyte Corp (INCY) as of January 26, 2023, with a value of $3 Million.

Latest Holdings of Vijay K Iyengar

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INCY Incyte Corp 2023-01-26 42,835 62.01 2,656,198

Holding Weightings of Vijay K Iyengar


Vijay K Iyengar Form 4 Trading Tracker

According to the SEC Form 4 filings, Vijay K Iyengar has made a total of 10 transactions in Incyte Corp (INCY) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Incyte Corp is the sale of 7,000 shares on January 26, 2023, which brought Vijay K Iyengar around $595,000.

Insider Trading History of Vijay K Iyengar

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
INCY
Incyte Corp
2023-01-26
Sell
7,000.00
-14.05%
$85.00
$595,000.00
42,835.00
$62.01
-27.05%
2023-01-30
INCY
Incyte Corp
2022-12-23
Sell
17,324.00
-31.40%
$80.80
$1,399,780.00
37,855.00
$62.01
-23.25%
2022-12-28
INCY
Incyte Corp
2022-07-07
Sell
5,787.00
-12.55%
$79.38
$459,372.00
40,313.00
$62.01
-21.88%
2022-07-11
INCY
Incyte Corp
2021-07-29
Sell
4,911.00
-15.39%
$78.29
$384,482.00
27,005.00
$62.01
-20.79%
-
INCY
Incyte Corp
2021-01-25
Sell
5,116.00
-16.36%
$99.00
$506,484.00
26,158.00
$62.01
-37.36%
-
INCY
Incyte Corp
2020-07-08
Sell
3,595.00
-12.18%
$108.06
$388,476.00
25,926.00
$62.01
-42.62%
-
INCY
Incyte Corp
2020-06-19
Sell
7,866.00
-24.01%
$105.00
$825,930.00
24,901.00
$62.01
-40.94%
-
INCY
Incyte Corp
2019-12-02
Sell
7,866.00
-30.88%
$95.00
$747,270.00
17,609.00
$62.01
-34.73%
-
INCY
Incyte Corp
2018-01-02
Sell
5,000.00
-36.56%
$97.26
$486,300.00
8,676.00
$62.01
-36.24%
-
Total 9
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vijay K Iyengar Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vijay K Iyengar Ownership Network

Ownership Network List of Vijay K Iyengar

No Data

Ownership Network Relation of Vijay K Iyengar


Vijay K Iyengar Owned Company Details

What does Incyte Corp do?

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Who are the key executives at Incyte Corp?

Vijay K Iyengar is the EVP GPS & BD & & Licensing of Incyte Corp. Other key executives at Incyte Corp include Principal Accounting Officer Thomas Tray , EVP & Head of Tech. Operations Michael James Morrissey , and EVP & General Manager & Europe Jonathan Elliott Dickinson .

Incyte Corp (INCY) Insider Trades Summary

Over the past 18 months, Vijay K Iyengar made 3 insider transaction in Incyte Corp (INCY) with a net sale of 30,111. Other recent insider transactions involving Incyte Corp (INCY) include a net purchase of 2,510,403 shares made by Baker Bros. Advisors Lp , a net sale of 46,866 shares made by Barry P Flannelly , and a net sale of 2,787 shares made by Thomas Tray .

In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 208,851 shares of Incyte Corp (INCY) were sold and 2,510,403 shares were bought by its insiders, resulting in a net purchase of 2,301,552 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Incyte Corp Insider Transactions

No Available Data

Vijay K Iyengar Mailing Address

Above is the net worth, insider trading, and ownership report for Vijay K Iyengar. You might contact Vijay K Iyengar via mailing address: 1801 Augustine Cut-off, Wilmington De 19803.